CLOs on the Move

Blue Ridge Community Health Service

www.brchs.com

 
Blue Ridge Community Health Service is a Hendersonville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Accordant Health Services

Accordant helps members manage their rare or complex conditions.

VetnCare

VetnCare is a collective of AAHA accredited animal hospitals located in Northern California that believe the highest standard of veterinary care comes from veterinarian owned hospitals, led by their clinical teams.

Vein Specialists of the South

Vein Specialists of the South is a vein clinic that provides minimally invasive treatments for varicose veins, spider veins, venous ulcers, and leg swelling.

Vericred

Vericred, Inc. is a healthcare data services company, operating at the intersection of health insurance and technology. Vericred serves companies who are transforming today`s healthcare experience, from care management to finding the right insurance plan. Its datasets are the foundation on which the healthcare industry builds innovative solutions. Vericred`s health insurance data platform, which is comprised of plan design and rate data, provider-network data and formulary data, offers a solution to an industry plagued by highly fragmented, rapidly changing data that currently exists in non-standard and non-structured formats.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.